BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 32515246)

  • 1. Novel Insights Into the Effects of Interleukin 6 Antagonism in Non-ST-Segment-Elevation Myocardial Infarction Employing the SOMAscan Proteomics Platform.
    George MJ; Kleveland O; Garcia-Hernandez J; Palmen J; Lovering R; Wiseth R; Aukrust P; Engmann J; Damås JK; Hingorani AD; Gullestad L; Casas JP; Ueland T
    J Am Heart Assoc; 2020 Jun; 9(12):e015628. PubMed ID: 32515246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction.
    Kleveland O; Ueland T; Kunszt G; Bratlie M; Yndestad A; Broch K; Holte E; Ryan L; Amundsen BH; Bendz B; Aakhus S; Espevik T; Halvorsen B; Mollnes TE; Wiseth R; Gullestad L; Aukrust P; Damås JK
    Int J Cardiol; 2018 Nov; 271():1-7. PubMed ID: 29961572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction.
    Ueland T; Kleveland O; Michelsen AE; Wiseth R; Damås JK; Holven KB; Aukrust P; Gullestad L; Yndestad A; Halvorsen B
    Int J Cardiol; 2019 Jan; 274():348-350. PubMed ID: 29961573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction.
    Broch K; Anstensrud AK; Woxholt S; Sharma K; Tøllefsen IM; Bendz B; Aakhus S; Ueland T; Amundsen BH; Damås JK; Berg ES; Bjørkelund E; Bendz C; Hopp E; Kleveland O; Stensæth KH; Opdahl A; Kløw NE; Seljeflot I; Andersen GØ; Wiseth R; Aukrust P; Gullestad L
    J Am Coll Cardiol; 2021 Apr; 77(15):1845-1855. PubMed ID: 33858620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction.
    Orrem HL; Nilsson PH; Pischke SE; Kleveland O; Yndestad A; Ekholt K; Damås JK; Espevik T; Bendz B; Halvorsen B; Gregersen I; Wiseth R; Andersen GØ; Ueland T; Gullestad L; Aukrust P; Barratt-Due A; Mollnes TE
    Front Immunol; 2018; 9():2035. PubMed ID: 30258440
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial.
    Kleveland O; Kunszt G; Bratlie M; Ueland T; Broch K; Holte E; Michelsen AE; Bendz B; Amundsen BH; Espevik T; Aakhus S; Damås JK; Aukrust P; Wiseth R; Gullestad L
    Eur Heart J; 2016 Aug; 37(30):2406-13. PubMed ID: 27161611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tocilizumab increases citrullinated histone 3 in non-ST segment elevation myocardial infarction.
    Helseth R; Kleveland O; Ueland T; Wiseth R; Damas JK; Broch K; Michelsen A; Bendz B; Gullestad L; Aukrust P; Seljeflot I
    Open Heart; 2021 May; 8(1):. PubMed ID: 33972404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput targeted proteomics discovery approach and spontaneous reperfusion in ST-segment elevation myocardial infarction.
    Shavadia JS; Granger CB; Alemayehu W; Westerhout CM; Povsic TJ; Brener SJ; van Diepen S; Defilippi C; Armstrong PW
    Am Heart J; 2020 Feb; 220():137-144. PubMed ID: 31812755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction.
    Holte E; Kleveland O; Ueland T; Kunszt G; Bratlie M; Broch K; Michelsen AE; Bendz B; Amundsen BH; Aakhus S; Damås JK; Gullestad L; Aukrust P; Wiseth R
    Heart; 2017 Oct; 103(19):1521-1527. PubMed ID: 28432157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial.
    Huse C; Anstensrud AK; Michelsen AE; Ueland T; Broch K; Woxholt S; Yang K; Sharma K; Tøllefsen IM; Bendz B; Amundsen BH; Damås JK; Berg ES; Bjørkelund E; Quiles-Jiménez A; Bjerkeli V; Bendz C; Kleveland O; Stensaeth KH; Opdahl A; Kløw NE; Andersen GØ; Wiseth R; Halvorsen B; Gullestad L; Seljeflot I; Aukrust P; Osnes L; Dahl TB
    EBioMedicine; 2022 Jun; 80():104013. PubMed ID: 35504178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-Like Growth Factor Binding Protein 4 Fragments Provide Incremental Prognostic Information on Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction.
    Hjortebjerg R; Lindberg S; Pedersen S; Mogelvang R; Jensen JS; Oxvig C; Frystyk J; Bjerre M
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28314798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Large-Scale Aptamer-Based Proteomic Profiling to Planned Myocardial Infarctions.
    Jacob J; Ngo D; Finkel N; Pitts R; Gleim S; Benson MD; Keyes MJ; Farrell LA; Morgan T; Jennings LL; Gerszten RE
    Circulation; 2018 Mar; 137(12):1270-1277. PubMed ID: 29222138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Between Peak Troponin Values and Long-Term Ischemic Events Among Medically Managed Patients With Acute Coronary Syndromes.
    Goldstein SA; Newby LK; Cyr DD; Neely M; Lüscher TF; Brown EB; White HD; Ohman EM; Roe MT; Hamm CW
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28400368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction-a registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial).
    Erlinge D; Koul S; Eriksson P; Scherstén F; Omerovic E; Linder R; Östlund OP; Wallentin L; Fröbert O; James S
    Am Heart J; 2016 May; 175():36-46. PubMed ID: 27179722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015.
    Puymirat E; Simon T; Cayla G; Cottin Y; Elbaz M; Coste P; Lemesle G; Motreff P; Popovic B; Khalife K; Labèque JN; Perret T; Le Ray C; Orion L; Jouve B; Blanchard D; Peycher P; Silvain J; Steg PG; Goldstein P; Guéret P; Belle L; Aissaoui N; Ferrières J; Schiele F; Danchin N;
    Circulation; 2017 Nov; 136(20):1908-1919. PubMed ID: 28844989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics in Hypothermia as Adjunctive Therapy in Patients with ST-Segment Elevation Myocardial Infarction: A CHILL-MI Substudy.
    Mohammad MA; Noc M; Lang I; Holzer M; Clemmensen P; Jensen U; Metzler B; Erlinge D
    Ther Hypothermia Temp Manag; 2017 Sep; 7(3):152-161. PubMed ID: 28437237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editor's Choice-Acute versus subacute angiography in patients with non-ST-elevation myocardial infarction - the NONSTEMI trial phase I.
    Stengaard C; Sørensen JT; Rasmussen MB; Søndergaard HM; Dodt KK; Niemann T; Frost L; Jensen T; Hansen TM; Riddervold IS; Rasmussen CH; Giebner M; Aarøe J; Maeng M; Christiansen EH; Kristensen SD; Bøtker HE; Terkelsen CJ
    Eur Heart J Acute Cardiovasc Care; 2017 Sep; 6(6):490-499. PubMed ID: 27154526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials.
    Bikdeli B; Erlinge D; Valgimigli M; Kastrati A; Han Y; Steg PG; Stables RH; Mehran R; James SK; Frigoli E; Goldstein P; Li Y; Shahzad A; Schüpke S; Mehdipoor G; Chen S; Redfors B; Crowley A; Zhou Z; Stone GW
    Circulation; 2023 Oct; 148(16):1207-1219. PubMed ID: 37746717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Relative Conditional Survival Estimates on Patient Prognosis After Percutaneous Coronary Intervention.
    Baart SJ; van Domburg RT; Janssen-Heijnen MLG; Deckers JW; Akkerhuis KM; Daemen J; van Geuns RJ; Boersma E; Kardys I
    Circ Cardiovasc Qual Outcomes; 2017 Jun; 10(6):. PubMed ID: 28619724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ST-segment elevation on intracoronary electrocardiogram after percutaneous coronary intervention is associated with worse outcome in patients with non-ST-segment elevation myocardial infarction.
    Hishikari K; Kakuta T; Lee T; Murai T; Yonetsu T; Isobe M
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):E113-21. PubMed ID: 26152334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.